<span><b>About Nevro</b><b></b></span>
Nevro (NYSE:
NVRO) is a global medical device company headquartered in Redwood City,
California. We are focused on delivering comprehensive, life-changing solutions
that continue to set the standard for enduring patient outcomes in chronic pain
treatment. The company started with a simple mission to help more patients
suffering from debilitating pain and developed its proprietary 10 kHz Therapy™,
an evidence-based, non-pharmacologic innovation that has impacted the lives of
more than 100,000 patients globally.
<span>Nevro’s
comprehensive HFX™ spinal cord stimulation (SCS) platform includes a Senza SCS
system and support services for the treatment of chronic trunk and limb pain
and painful diabetic neuropathy. Senza®,
Senza II®, Senza Omnia™, and Senza HFX iQ™ are the only SCS systems that
deliver Nevro's proprietary 10 kHz Therapy. HFX iQ, Nevro’s latest innovation,
is the first and only SCS System that uses Artificial Intelligence to optimize
and maintain pain relief using each patient's response1.Nevro’s
unique support services provide every patient with an HFX Coach™ throughout
their pain relief journey and every physician with HFX Cloud™ insights for
enhanced patient and practice management.
<b><u></u></b></span>